(Q51635766)

8 April 2018

title

HA-1A in septic patients with ARDS: results from the pivotal trial. (English)

1 reference

8 April 2018

acute respiratory distress syndrome

main subject

1 reference

L M Bigatello

1

1 reference

8 April 2018

R E Greene

2

1 reference

8 April 2018

C L Sprung

3

1 reference

8 April 2018

E A Panacek

4

1 reference

8 April 2018

R C Straube

5

1 reference

8 April 2018

J L Zimmerman

6

1 reference

8 April 2018

R J Maunder

7

1 reference

8 April 2018

P N Lanken

8

1 reference

8 April 2018

E Pile-Spellmann

9

1 reference

8 April 2018

K S Stanek

10

1 reference

8 April 2018

publication date

1 May 1994

1 reference

8 April 2018

published in

Intensive Care Medicine

1 reference

8 April 2018

volume

20

1 reference

8 April 2018

issue

5

1 reference

8 April 2018

page(s)

328-334

1 reference

8 April 2018

https://scigraph.springernature.com/pub.10.1007/bf01720904

exact match

0 references

cites work

A multicenter registry of patients with acute respiratory distress syndrome. Physiology and outcome.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF01720904

Effects of recombinant human tumor necrosis factor alpha, lymphotoxin, and Escherichia coli lipopolysaccharide on hemodynamics, lung microvascular permeability, and eicosanoid synthesis in anesthetized sheep

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF01720904

An expanded definition of the adult respiratory distress syndrome

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF01720904

Endotoxin and lung injury

21 January 2018

1 reference

12 December 2020

Causes of mortality in patients with the adult respiratory distress syndrome

1 reference

12 December 2020

Pulmonary vascular obstruction in severe ARDS: angiographic alterations after i.v. fibrinolytic therapy.

1 reference

12 December 2020

A critical evaluation of new agents for the treatment of sepsis

1 reference

12 December 2020

Acute respiratory distress in adults

1 reference

12 December 2020

Prevention of gram-negative shock and death in surgical patients by antibody to endotoxin core glycolipid.

1 reference

12 December 2020

Adult respiratory distress syndrome: risk with common predispositions

1 reference

12 December 2020

A controlled trial of HA-1A in a canine model of gram-negative septic shock.

1 reference

12 December 2020

Early methylprednisolone treatment for septic syndrome and the adult respiratory distress syndrome

1 reference

12 December 2020

Protection against gram-negative bacteremia and endotoxemia with human monoclonal IgM antibodies

1 reference

12 December 2020

Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective study

1 reference

12 December 2020

Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli

1 reference

12 December 2020

High-dose corticosteroids in patients with the adult respiratory distress syndrome

1 reference

12 December 2020

A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. The XOMA Sepsis Study Group

1 reference

12 December 2020

Randomized double-blind, multicenter study of prostaglandin E1 in patients with the adult respiratory distress syndrome. Prostaglandin E1 Study Group

1 reference

12 December 2020

Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group

1 reference

12 December 2020

APACHE II: a severity of disease classification system

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01720904

1 reference

8 April 2018

1 reference

8 April 2018